HAE logo

Haemonetics (HAE)

Profile

Full Name

Haemonetics Corporation

Ticker Symbol

HAE

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

May 10, 1991

Indexes

Not included

Website

http://www.haemonetics.com

Employees

3657

Key Details

Price

$58.25(-1.97%)

Market cap

$2.93B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.31B(+12.01% YoY)

Annual EPS

$2.29(+2.23% YoY)

PE ratio

22.93

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$58.25
HAE price is $58.25

30-Day Relative Volume

0.55
HAE 30-day relative volume is 0.55

Price Performance

Price Today change

-1.97%
HAE price is down -1.97% today

Price YTD change

-25.4%
HAE price is down -25.4% since January 1st

Price 1-year change

-31.37%
HAE price is down -31.37% year-on-year

Price 3-year change

+2.52%
HAE price is up +2.52% over the past 3 years

Price Range

Price All-time high

$142.11
HAE price is currently -59.01% below its historical high of $142.11

Price 3-year low

$48.67
HAE price is currently +19.68% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.93B
HAE market capitalization is $2.93 billion

Market cap 3-year change

+0.74%
HAE market capitalization is up +0.74% over the past 3 years

Market cap All-time high

$7.09B
HAE market capitalization is currently -58.72% below its historical high of $7.09 billion

Market cap sector rank

86.43%
HAE market capitalization is higher than 86.43% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-1.08%
HAE shares outstanding is down -1.08% year-on-year

Shares Outstanding 3-Year Change

-1.73%
HAE shares outstanding is down -1.73% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.61
HAE beta is 0.61

200-day SMA

$75.69
HAE price is currently -23.04% below its 200-day simple moving average

50-day SMA

$63.75
HAE price is currently -8.62% below its 50-day simple moving average

RSI

38.19
HAE 14-day relative strength index is 38.19

Volume

0.55
HAE 30-day relative volume is 0.55

ATR

$2.56
HAE average true range is $2.56

10-day Historical Volatility

62.34%
HAE 10-day historical volatility is 62.34%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.31B
HAE annual revenue is $1.31 billion

Revenue Analysts estimate

$1.36B
HAE annual revenue is currently -3.72% lower than the consensus analysts' forecast

Revenue 1-year change

+12.01%
HAE annual revenue is up +12.01% year-on-year

Revenue Sector rank

82.64%
HAE annual revenue is higher than 82.64% of companies in Healthcare sector

EPS

EPS

$2.29
HAE annual earnings per share is $2.29

EPS Analysts estimate

$4.54
HAE annual earnings per share is currently -49.61% lower than the consensus analysts' forecast

EPS 1-year change

+2.23%
HAE annual earnings per share is up +2.23% year-on-year

EPS Sector rank

92.89%
HAE annual earnings per share is higher than 92.89% of companies in Healthcare sector

Profit

Gross profit

$691.55M
HAE annual gross profit is $691.55 million

Gross margin

52.83%
HAE annual gross profit margin is 52.83%

Operating profit

$164.88M
HAE annual operating income is $164.88 million

Operating margin

13.24%
HAE annual operating profit margin is 13.24%

Net income

$117.56M
HAE annual net profit is $117.56 million

Net margin

8.98%
HAE annual net profit margin is 8.98%

Expenses

Total expenses

$1.14B
HAE annual total expenses is $1.14 billion

Operating expenses

$518.25M
HAE annual total operating expenses is $518.25 million

Cost of goods sold

$617.51M
HAE annual cost of goods sold is $617.51 million

Selling, general & administrative expenses

$431.78M
HAE annual SGA is $431.78 million

Depreciation and amortization

$97.22M
HAE annual depreciation & amortization is $97.22 million

Interest expense

$13.02M
HAE annual interest expense is $13.02 million

Income tax

$34.31M
HAE annual income tax is $34.31 million

EBIT & EBITDA

EBIT

$164.88M
HAE annual earnings before interest & taxes is $164.88 million

EBITDA

$262.10M
HAE annual EBITDA is $262.10 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.20B
HAE annual total assets is $2.20 billion

Non current assets

$1.43B
HAE annual long term assets is $1.43 billion

Current assets

$768.90M
HAE annual total current assets is $768.90 million

Cash and cash equivalents

$178.80M
HAE annual cash & cash equivalents is $178.80 million

Accounts receivable

$206.56M
HAE annual accounts receivable is $206.56 million

Inventory

$317.20M
HAE annual inventory is $317.20 million

Liabilities

Total liabilities

$1.24B
HAE annual total liabilities is $1.24 billion

Long term liabilities

$935.25M
HAE annual total long term liabilities is $935.25 million

Current liabilities

$300.38M
HAE annual total current liabilities is $300.38 million

Accounts payable

$73.36M
HAE annual accounts payable is $73.36 million

Debt

Total debt

$807.79M
HAE annual total debt is $807.79 million

Total debt 1-year change

+5.47%
HAE annual total debt is up +5.47% year-on-year

Long term debt

$797.56M
HAE annual long term debt is $797.56 million

Short term debt

$10.23M
HAE annual short term debt is $10.23 million

Equity & Capital

Shareholders equity

$959.96M
HAE annual stockholders equity is $959.96 million

Book value

$959.96M
HAE annual book value is $959.96 million

Retained earnings

$360.46M
HAE annual retained earnings is $360.46 million

Working capital

$468.52M
HAE annual working capital is $468.52 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$181.75M
HAE annual cash flow from operations is $181.75 million

Cash from operations 1-year change

-33.44%
HAE annual cash flow from operations is down -33.44% year-on-year

Cash from investing

-$322.39M
HAE annual cash flow from investing activities is -$322.39 million

Cash from investing 1-year change

-124.21%
HAE annual cash flow from investing activities is down -124.21% year-on-year

Cash from financing

$38.16M
HAE annual cash flow from financing activities is $38.16 million

Cash from financing 1-year change

+138.02%
HAE annual cash flow from financing activities is up +138.02% year-on-year

CAPEX

CAPEX

$66.30M
HAE annual capital expenditures is $66.30 million

CAPEX 1-year change

-39.84%
HAE annual capital expenditures is down -39.84% year-on-year

Free Cash Flow

Free cash flow

$115.45M
HAE annual free cash flow is $115.45 million

Free cash flow 1-year change

-29.11%
HAE annual free cash flow is down -29.11% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

52.83%
HAE annual gross profit margin is 52.83%

Operating margin

13.24%
HAE annual operating profit margin is 13.24%

Net margin

8.98%
HAE annual net profit margin is 8.98%

ROA & ROE

ROA

5.69%
HAE annual return on assets is 5.69%

ROE

13.22%
HAE annual return on equity is 13.22%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

22.93
HAE price to earnings ratio is 22.93

PE ratio Sector rank

43.63%
HAE price to earnings ratio is higher than 43.63% of companies in Healthcare sector

PB Ratio

PB ratio

3.23
HAE price to book ratio is 3.23

PB ratio Sector rank

73.83%
HAE price to book ratio is higher than 73.83% of companies in Healthcare sector

PS Ratio

PS ratio

2.13
HAE price to sales ratio is 2.13

PS ratio Sector rank

44.1%
HAE price to sales ratio is higher than 44.1% of companies in Healthcare sector

Enterprise value

Enterprise value

$3.83B
HAE enterprise value is $3.83 billion

Enterprise value Sector rank

86.53%
HAE enterprise value is higher than 86.53% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

12.96
HAE EV/EBITDA is 12.96

EV/EBITDA Sector rank

85.65%
HAE EV/EBITDA is higher than 85.65% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.56
HAE annual current ratio is 2.56

Quick ratio

1.50
HAE annual quick ratio is 1.50

Leverage

Debt to equity

0.84
HAE annual debt to equity ratio is 0.84

Interest coverage ratio

12.67
HAE annual interest coverage ratio is 12.67

Risk & Stability

Piotroski F-Score

6
HAE piotroski f-score is 6

Altman Z-Score

2.75
HAE altman z-score is 2.75

Analyst ratings

Recent major analysts updates

Feb 7, 25 Raymond James
Strong Buy
Feb 7, 25 Needham
Buy
Feb 7, 25 JMP Securities
Market Outperform
Feb 7, 25 Barrington Research
Outperform
Dec 6, 24 JP Morgan
Overweight
Dec 4, 24 Barrington Research
Outperform
Dec 3, 24 Needham
Buy
Nov 15, 24 Needham
Buy
Nov 8, 24 Raymond James
Strong Buy
Nov 8, 24 Barrington Research
Outperform

Institutional Ownership

Similar stocks

BTSG logo
BrightSpring Health Services (BTSG)
AKRO logo
Akero Therapeutics (AKRO)
AMED logo
Amedisys (AMED)
SHC logo
Sotera Health (SHC)
PRCT logo
PROCEPT BioRobotics (PRCT)
MRUS logo
Merus NV (MRUS)
TMDX logo
TransMedics (TMDX)
OGN logo
Organon & Co (OGN)
PRVA logo
Privia Health (PRVA)
  • What is the ticker symbol for Haemonetics?
  • Does Haemonetics pay dividends?
  • What sector is Haemonetics in?
  • What industry is Haemonetics in?
  • What country is Haemonetics based in?
  • When did Haemonetics go public?
  • Is Haemonetics in the S&P 500?
  • Is Haemonetics in the NASDAQ 100?
  • Is Haemonetics in the Dow Jones?
  • When was Haemonetics's last earnings report?
  • When does Haemonetics report earnings?
  • Should I buy Haemonetics stock now?

What is the ticker symbol for Haemonetics?

The ticker symbol for Haemonetics is NYSE:HAE

Does Haemonetics pay dividends?

No, Haemonetics does not pay dividends

What sector is Haemonetics in?

Haemonetics is in the Healthcare sector

What industry is Haemonetics in?

Haemonetics is in the Medical Devices industry

What country is Haemonetics based in?

Haemonetics is headquartered in United States

When did Haemonetics go public?

Haemonetics's initial public offering (IPO) was on May 10, 1991

Is Haemonetics in the S&P 500?

No, Haemonetics is not included in the S&P 500 index

Is Haemonetics in the NASDAQ 100?

No, Haemonetics is not included in the NASDAQ 100 index

Is Haemonetics in the Dow Jones?

No, Haemonetics is not included in the Dow Jones index

When was Haemonetics's last earnings report?

Haemonetics's most recent earnings report was on Feb 6, 2025

When does Haemonetics report earnings?

The next expected earnings date for Haemonetics is May 8, 2025

Should I buy Haemonetics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page